🇺🇸 FDA
Patent

US 11918638

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

granted A61KA61K2039/5254A61K2039/55

Quick answer

US patent 11918638 (Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5254, A61K2039/55, A61K39/12, A61P